The company is advancing Phase 3 trials for MM120 in Generalized Anxiety Disorder (GAD) and planning for MDD trials. MindMed secured a new formulation patent, extending IP protection to 2041.

Trump announces $5 million 'gold card' visa US President Donald Trump unveiled plans to sell a new 'gold card' residency permit for $5 million, positioning it as a way to attract wealthy investors ...

Generalized anxiety disorder (GAD) is a type of excessive worrying that consumes the lives of people who experience it. Symptoms can include fatigue, headaches, shortness of breath, and having a hard ...

Gor Mahia player takes out referee with ferocious shot in Al Ahly loss Gor Mahia's Gad Mathews left a match official sprawling on the floor after hitting him with a ferocious shot during their CAF ...

Stock market today: Nasdaq hits record high as major earnings from big tech loom By Investing.com - Oct 29, 2024 30 Investing.com -- The Nasdaq closed at record highs Tuesday, shrugging off mixed ...